Nalaganje...
Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer
INTRODUCTION: Lung cancer is the leading cause of cancer-related mortality. Platinum-based chemotherapy is the usual first-line treatment for advanced nonsmall cell lung cancer (NSCLC), although an efficacy plateau has been reached with this approach. Bevacizumab is a recombinant, humanized, monoclo...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3012552/ https://ncbi.nlm.nih.gov/pubmed/21221196 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|